http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014159067-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2808f5779912ea7fdb826981e34ce015 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D495-14 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55 |
| filingDate | 2014-03-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bf128d7fad8e49a8c684b5f5d99f20e7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_74539a28a23acbc1db22dc535973d93f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_20d2d4aa77ea8a4f5f98e9c4436f4b88 |
| publicationDate | 2014-10-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-2014159067-A1 |
| titleOfInvention | Thienylindole azepines as serotonin 5-ht2c receptor ligands and uses thereof |
| abstract | The present invention generally relates to a series of compounds, to pharmaceutical compositions containing the compounds, and to use of the compounds and compositions as therapeutic agents. More specifically, compounds of the present invention are thienylindole azepines. These compounds are serotonin receptor (5-HT 2c ) ligands and are useful for treating diseases, disorders, and conditions wherein modulation of the activity of serotonin receptors (5-HT 2c ) is desired (e.g. addiction, anxiety, depression, obesity, and others). |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015066344-A1 |
| priorityDate | 2013-03-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 532.